Transverse Medical, Inc.
PrivateLast Round
Series B
Extension
Apr 28, 2025
Total Funding Raised
$13.25M
Company Overview
Transverse Medical, Inc. is a biotechnology company that develops the POINT-GUARD™ Cerebral Embolic Protection device to reduce the risk of stroke during cardiovascular and structural heart procedures.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Transverse Medical, Inc. Comparables
Compare Transverse Medical, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Protembis GmbH | 91% | |
| Emboline | 90% | |
| Emblok | 88% |
Transverse Medical, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Apr 28, 2025 | ||||
| Series B Extension | Aug 1, 2023 | ||||
| Grant | Nov 21, 2019 | ||||
| VC Round | May 24, 2017 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 16, 2025
Grew 50% QoQ, from 12 to 18 employees.
- Jun 4, 2025
Grew 45% QoQ from 11 to 16 employees.
Transverse Medical, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Transverse Medical, Inc.'s valuation, stock price, and market status.
Is Transverse Medical a public or private company?
Transverse Medical is a private company.
What is the current stock price of Transverse Medical?
Transverse Medical is a private company with no public stock price. No recent secondary market data is available.
How much is Transverse Medical worth (valuation)?
Valuation information for Transverse Medical is not publicly available.
Can I buy Transverse Medical stock?
Transverse Medical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Transverse Medical's last funding round?
Transverse Medical's most recent funding round was Series B Extension on April 28, 2025.
Who are the main investors in Transverse Medical?
Investor information for Transverse Medical is not publicly disclosed.
Will Transverse Medical IPO soon?
No public IPO plans have been announced for Transverse Medical.
How can I track Transverse Medical secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Transverse Medical's secondary market activity and sign up for updates.